Building on the 2021 Interim guidance, this second version and update, incorporates the lessons and feedback from the hepatitis pilots that successfully demonstrated the feasibility of measuring hepatitis B and C impact targets to demonstrate elimination, whilst highlighting challenges caused by high disease burden in some countries, as well as delays in reaching mortality targets due to the long natural history of disease progression to liver cirrhosis and hepatocellular carcinoma.
Resources
Drug services professional
Around half of current injecting drug users will have hepatitis C, although this prevalence rate varies across the country. Find here tools, resources and other relevant documents to help drugs service staff raise awareness of hepatitis C amongst service users, and improve testing and access to care.
Showing 1 to 10 of 321 resources
-
Guidance for country validation of viral hepatitis elimination and path to elimination
UK, Rest of World 05 Oct 2023 Reports & Research, Strategy & Planning PDF -
National Hepatitis C ODN Event 2023 - Slides
On September 12th 2023, HCV Action held our latest annual National ODN Stakeholder Event. This event is HCV Action’s annual gathering of ODN representatives and the wider hepatitis C professional community, and is intended to be an opportunity to discuss progress towards elimination, showcase best practice and successful projects, and identify solutions to common challenges in reaching elimination.UK, England Tools & Templates PDF -
Prevention, diagnosis and treatment of blood borne viruses in Wales: Hepatitis B, hepatitis C and HIV - Annual report 2023
This report provides information on the epidemiology, prevention and control of hepatitis B, hepatitis C and HIV in Wales to end of 2022. The report is aimed at policy makers, health service clinicians and planners, commissioners, criminal justice, third sector agencies and academia.Wales 28 Jul 2023 Reports & Research PDF -
Webinar: Engaging socially excluded groups - lessons from hepatitis C
On 13th July 2023, HCV Action held a webinar to explore how lessons from the hepatitis C elimination programme and models used to deliver HCV-related healthcare can be applied to other efforts to engage socially excluded (or 'inclusion health') groups in healthcare. Thank you to our speakers: Leila Reid (The Hepatitis C Trust) Julia Sheehan (The Hepatitis C Trust) Mark Gillyon-Powell (Head of Programme - HCV Elimination, NHS England) Dr Binta Sultan (Consultant Physician in Inclusion Health, University College London Hospital)UK 21 Jul 2023 Other Video -
Inclusion Health webinar - July 2023 - Slides
On 13th July 2023, HCV Action held a webinar to explore how lessons from the hepatitis C elimination programme and models used to deliver HCV-related healthcare can be applied to other efforts to engage socially excluded (or 'inclusion health') groups in healthcare. Thank you to our speakers: Leila Reid (The Hepatitis C Trust) Julia Sheehan (The Hepatitis C Trust) Mark Gillyon-Powell (Head of Programme - HCV Elimination, NHS England) Dr Binta Sultan (Consultant Physician in Inclusion Health, University College London Hospital)UK 13 Jul 2023 Other PDF -
Good practice case study: Delivering a High-Intensity Test and Treat initiative in Turning Point drug services
Hepatitis C Trust peers, ODN nurses, and Turning Point drug service staff worked together to conduct a High-Intensity Test and Treat (HITT) project in Oxfordshire during the summer of 2021. Carried out across four different Turning Point services in Oxfordshire, resources and data were shared between the ODN and the drug services to identify a list of people to follow up with and offer a test.UK, England, South East 19 May 2023 Case study PDF -
HCV Action Webinar - Hepatitis C Micro-elimination - Slides
On 18 April 2023, HCV Action held a webinar to hear from people working in different services that have achieved 'micro-elimination' of hepatitis C, reaching the micro-elimination criteria for a specific population or setting. Speakers at the webinar provided examples for other services to learn from on achieving micro-elimination and maintaining micro-elimination status.UK Other PDF -
WHO: New recommendation on hepatitis C virus testing and treatment for people at ongoing risk of infection
In 2022, the World Health Organization published the Consolidated guidelines on HIV, viral hepatitis and STI prevention, diagnosis, treatment and care for key populations. These guidelines outline a public health response to HIV, viral hepatitis and sexually transmitted infections (STIs) for 5 key populations (men who have sex with men, sex workers, people in prisons and other closed settings, people who inject drugs and trans and gender diverse people).UK, Rest of World 14 Apr 2023 Reports & Research, Tools & Templates, Strategy & Planning PDF -
Shooting Up: infections and other injecting-related harms among people who inject drugs in the UK, 2023 update
This report describes the extent of infections and injecting-related harms among people who inject drugs (PWID) in the United Kingdom. This report is an update issued in March 2023 and includes the most recent data, which covers the period up to the end of 2021.UK 22 Mar 2023 Reports & Research PDF -
Taking the initiative: how England is eliminating hepatitis C
This report explores the unprecedented hepatitis C elimination programme developed since 2019 between NHS England, pharmaceutical industry providers, voluntary sector bodies and other partners, and profiles ‘elimination initiatives’ that have been developed in different parts of the country and wider health and care system as a result.England 21 Feb 2023 Reports & Research PDF